Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Cary

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Urologic Oncology|May 26, 2020
Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levelsRyan W Speir, Adam C Calaway, Lawrence H Einhorn, et al.
Journal of Robotic Surgery|September 18, 2016
Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomySanoj Punnen, K Clint Cary, Allison S Glass, et al.
The Journal of Urology|November 5, 2013
Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registryK Clint Cary, Nirmish Singla, Janet E Cowan, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
BMC Cancer|October 26, 2018
Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomesEllen Hollands Steffensen, Clint Cary, Jørgen Bjerggaard Jensen, et al.
Cancer|February 6, 2014
Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registryK Clint Cary, Alan Paciorek, Mahesh J Fuldeore, et al.
Urologic Oncology|October 3, 2018
A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgeryAdam C Calaway, M Francesca Monn, Clinton D Bahler, et al.
European Urology|April 5, 2026
Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ TumorParth U Thakker, Connor Drake, Jiping Zeng, et al.
Urologic Oncology|February 14, 2026
Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burdenJiping Zeng, Parth Thakker, Timothy A Masterson, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Urologic Oncology|May 26, 2020
Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levelsRyan W Speir, Adam C Calaway, Lawrence H Einhorn, et al.
Journal of Robotic Surgery|September 18, 2016
Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomySanoj Punnen, K Clint Cary, Allison S Glass, et al.
The Journal of Urology|November 5, 2013
Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registryK Clint Cary, Nirmish Singla, Janet E Cowan, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
BMC Cancer|October 26, 2018
Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomesEllen Hollands Steffensen, Clint Cary, Jørgen Bjerggaard Jensen, et al.
Cancer|February 6, 2014
Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registryK Clint Cary, Alan Paciorek, Mahesh J Fuldeore, et al.
Urologic Oncology|October 3, 2018
A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgeryAdam C Calaway, M Francesca Monn, Clinton D Bahler, et al.
European Urology|April 5, 2026
Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ TumorParth U Thakker, Connor Drake, Jiping Zeng, et al.
Urologic Oncology|February 14, 2026
Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burdenJiping Zeng, Parth Thakker, Timothy A Masterson, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Pageof 13